 |
|
CLINICAL AND HISTOLOGICAL OBSERVATIONS ON A CASE OF SCLERODERMA TREATED WITH CORTISONE
MATTHEW TAUBENHAUS, M.D.;
MAURICE LEV, M.D.
AMA Arch Intern Med. 1951;87(4):583-593.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
SINCE the pathological changes of scleroderma involve to a great extent collagen fibers, this disease has been frequently grouped together with other conditions affecting collagen, such as lupus erythematosus disseminatus, rheumatic fever, polyarteritis nodosa and dermatomyositis. Kkmperer1 recently warned against using the term "collagen diseases," expressing the view that although certain common changes are observed in all these conditions there is no evidence that they are etiologically or functionally the same. Among the great variety of diseases which have shown a favorable therapeutic response to pituitary adrenocorticotropic hormone (ACTH) or cortisone, this group, however, involving mesenchymal structures seems to be particularly influenced by use of the hormones, in many cases resulting in an improvement of the condition. Thorn and his co-workers2 separated diseases in which ACTH and cortisone appear "most useful" from those in which the hormones "may be useful" and those in which their value is questionable.
. . . [Full Text PDF of this Article]
Author Affiliations
CHICAGO
From the Department of Medicine, Michael Reese Hospital, and the Department of Pathology, University of Illinois College of Medicine.
Footnotes
This work was done under the auspices of the Rheumatoid Arthritis Research Group of Michael Reese Hospital (S. Soskin, chairman) and was aided by a grant from the United States Public Health Service (RG 2522).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
